Related references
Note: Only part of the references are listed.Myofilament Protein Gene Mutation Screening and Outcome of Patients With Hypertrophic Cardiomyopathy
Iacopo Olivotto et al.
MAYO CLINIC PROCEEDINGS (2012)
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Bernard J. Gersh et al.
CIRCULATION (2011)
Septal Reduction Therapy for Obstructive Hypertrophic Cardiomyopathy and Sudden Death What Statistics Cannot Tell You
Rick A. Nishimura et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2010)
Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy
Oliver Bruder et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations
Francesca Girolami et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Rory O'Hanlon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Myocardial Fibrosis as an Early Manifestation of Hypertrophic Cardiomyopathy
Carolyn Y. Ho et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Device complications and inappropriate implantable cardioverter defibrillator shocks in patients with hypertrophic cardiomyopathy
G. Lin et al.
HEART (2009)
Long-term survival after cardiac arrest in hypertrophic cardiomyopathy
Barry J. Maron et al.
HEART RHYTHM (2009)
Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy
Martin S. Maron et al.
CIRCULATION-HEART FAILURE (2008)
Bethesda Conference #36 and the European Society of Cardiology Consensus Recommendations Revisited A Comparison of US and European Criteria for Eligibility and Disqualification of Competitive Athletes With Cardiovascular Abnormalities
Antonio Pelliccia et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Prevention of hypertrophic cardiomyopathy-related deaths: theory and practice
P. Elliott et al.
HEART (2008)
Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy
Barry J. Maron et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction
Martin S. Maron et al.
CIRCULATION (2006)
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation - Executive summary
Valentin Fuster et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy
Kevin M. Harris et al.
CIRCULATION (2006)
Relevance of coronary microvascular flow impairment to long-term remodeling and systolic dysfunction in hypertrophic cardiomyopathy
I Olivotto et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy
SR Ommen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy
MV Sherrid et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Glycogen storage diseases presenting as hypertrophic cardiomyopathy
M Arad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Adverse prognosis of patients with hypertrophic cardiomyopathy who have epicardial coronary artery disease
P Sorajja et al.
CIRCULATION (2003)
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy - A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Gcuidelines
RA Vogel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Sudden death in young athletes
BJ Maron
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Clinical course of hypertrophic cardiomyopathy with survival to advanced age
BJ Maron et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy
JG Crilley et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Hypertrophic cardiomyopathy in a large community-based population: Clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration
MJM Kofflard et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy
MS Maron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Assessment of diastolic function with Doppler tissue imaging to predict genotype in preclinical hypertrophic cardiomyopathy
CY Ho et al.
CIRCULATION (2002)
Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy
PM Elliott et al.
LANCET (2001)
Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
BJ Maron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)